Werewolf Therapeutics (HOWL) Competitors $1.90 +0.12 (+6.74%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends HOWL vs. ACET, RANI, STTK, RAIN, XLO, DSGN, KOD, ACRS, CMPS, and ITOSShould you be buying Werewolf Therapeutics stock or one of its competitors? The main competitors of Werewolf Therapeutics include Adicet Bio (ACET), Rani Therapeutics (RANI), Shattuck Labs (STTK), Rain Oncology (RAIN), Xilio Therapeutics (XLO), Design Therapeutics (DSGN), Kodiak Sciences (KOD), Aclaris Therapeutics (ACRS), COMPASS Pathways (CMPS), and iTeos Therapeutics (ITOS). These companies are all part of the "medical" sector. Werewolf Therapeutics vs. Adicet Bio Rani Therapeutics Shattuck Labs Rain Oncology Xilio Therapeutics Design Therapeutics Kodiak Sciences Aclaris Therapeutics COMPASS Pathways iTeos Therapeutics Werewolf Therapeutics (NASDAQ:HOWL) and Adicet Bio (NASDAQ:ACET) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, community ranking, valuation, analyst recommendations and dividends. Do analysts rate HOWL or ACET? Werewolf Therapeutics presently has a consensus target price of $12.00, suggesting a potential upside of 531.58%. Adicet Bio has a consensus target price of $7.50, suggesting a potential upside of 733.33%. Given Adicet Bio's higher possible upside, analysts plainly believe Adicet Bio is more favorable than Werewolf Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Werewolf Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Adicet Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Is HOWL or ACET more profitable? Adicet Bio has a net margin of 0.00% compared to Werewolf Therapeutics' net margin of -578.80%. Adicet Bio's return on equity of -53.85% beat Werewolf Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Werewolf Therapeutics-578.80% -58.83% -38.45% Adicet Bio N/A -53.85%-46.45% Does the MarketBeat Community prefer HOWL or ACET? Adicet Bio received 268 more outperform votes than Werewolf Therapeutics when rated by MarketBeat users. However, 68.89% of users gave Werewolf Therapeutics an outperform vote while only 58.63% of users gave Adicet Bio an outperform vote. CompanyUnderperformOutperformWerewolf TherapeuticsOutperform Votes3168.89% Underperform Votes1431.11% Adicet BioOutperform Votes29958.63% Underperform Votes21141.37% Do insiders & institutionals have more ownership in HOWL or ACET? 64.8% of Werewolf Therapeutics shares are owned by institutional investors. Comparatively, 83.9% of Adicet Bio shares are owned by institutional investors. 21.1% of Werewolf Therapeutics shares are owned by insiders. Comparatively, 19.1% of Adicet Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, HOWL or ACET? Werewolf Therapeutics has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. Comparatively, Adicet Bio has a beta of 1.81, indicating that its share price is 81% more volatile than the S&P 500. Which has preferable valuation & earnings, HOWL or ACET? Werewolf Therapeutics has higher earnings, but lower revenue than Adicet Bio. Werewolf Therapeutics is trading at a lower price-to-earnings ratio than Adicet Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWerewolf Therapeutics$19.94M4.25-$37.37M-$1.53-1.24Adicet Bio$24.99M2.97-$142.66M-$1.71-0.53 Does the media favor HOWL or ACET? In the previous week, Adicet Bio had 6 more articles in the media than Werewolf Therapeutics. MarketBeat recorded 10 mentions for Adicet Bio and 4 mentions for Werewolf Therapeutics. Werewolf Therapeutics' average media sentiment score of 0.48 beat Adicet Bio's score of 0.06 indicating that Werewolf Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Werewolf Therapeutics 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Adicet Bio 0 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAdicet Bio beats Werewolf Therapeutics on 9 of the 17 factors compared between the two stocks. Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Get Werewolf Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOWL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOWL vs. The Competition Export to ExcelMetricWerewolf TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$84.66M$6.99B$5.38B$8.84BDividend YieldN/A8.15%5.13%4.09%P/E Ratio-1.2411.10105.1417.83Price / Sales4.25362.031,233.15158.41Price / CashN/A52.5940.4136.29Price / Book0.9510.377.096.50Net Income-$37.37M$153.60M$119.65M$226.22M7 Day Performance7.34%4.60%2.25%4.03%1 Month Performance-44.12%-6.29%-2.33%4.92%1 Year Performance-20.17%33.41%33.98%29.30% Werewolf Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOWLWerewolf Therapeutics3.0935 of 5 stars$1.90+6.7%$12.00+531.6%-20.2%$84.66M$19.94M-1.2440Analyst ForecastGap UpACETAdicet Bio2.5312 of 5 stars$0.92-5.2%$7.50+714.9%-21.7%$79.69M$24.99M-0.5490Analyst DowngradeRANIRani Therapeutics3.1753 of 5 stars$2.03-1.0%$11.71+477.1%+3.5%$108.42M$2.72M-1.92110Analyst ForecastSTTKShattuck Labs2.6483 of 5 stars$1.01-9.0%$8.67+758.1%-56.9%$48.22M$1.66M-0.66100RAINRain OncologyN/A$1.21flatN/AN/A$44.02MN/A-0.5963XLOXilio Therapeutics1.905 of 5 stars$0.92-2.1%$4.00+334.8%-19.6%$40.44MN/A-0.5573DSGNDesign Therapeutics0.6632 of 5 stars$5.56+1.5%$7.00+25.9%+154.3%$314.79MN/A-6.5440KODKodiak Sciences2.979 of 5 stars$5.90+1.9%$3.50-40.7%+157.9%$310.46MN/A-1.6290ACRSAclaris Therapeutics3.8433 of 5 stars$4.32+9.1%$8.80+103.7%+366.7%$308.58M$31.25M-8.7186Analyst UpgradeInsider TradeAnalyst RevisionNews CoverageGap UpHigh Trading VolumeCMPSCOMPASS Pathways2.9186 of 5 stars$4.47-4.3%$30.67+586.8%-27.1%$305.50MN/A-2.03120Positive NewsITOSiTeos Therapeutics3.5107 of 5 stars$8.16+3.9%$31.50+286.0%-14.2%$298.09M$12.60M-2.5990 Related Companies and Tools Related Companies Adicet Bio Alternatives Rani Therapeutics Alternatives Shattuck Labs Alternatives Rain Oncology Alternatives Xilio Therapeutics Alternatives Design Therapeutics Alternatives Kodiak Sciences Alternatives Aclaris Therapeutics Alternatives COMPASS Pathways Alternatives iTeos Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HOWL) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Werewolf Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
